🚀 From Google Podcasts to Moon FM in No Time: Your Hassle-Free Migration Guide
👉

Gastrointestinal Cancer Update

Dr Neil Love

This series bridges the gap between research and patient care by providing medical oncologists and hematologists with ongoing access to the perspectives and opinions of national and international clinical investigators with expertise in gastrointestinal cancers.

  • 1 hour 2 minutes
    The Implications of Recent Datasets for the Current and Future Management of Gastrointestinal Cancers — An ESMO Congress 2024 Review
    Dr Tanios Bekaii-Saab from Mayo Clinic in Phoenix, Arizona, and Dr Philip A Philip from the Henry Ford Cancer Institute in Detroit, Michigan, discuss recent research presentations on the treatment of gastrointestinal cancers.
    6 November 2024, 8:39 pm
  • 59 minutes 21 seconds
    Practical Perspectives: Optimizing Diagnosis and Treatment for Patients with Desmoid Tumors
    Dr Thierry Alcindor from Dana-Farber Cancer Institute in Boston, Massachusetts, and Dr Mrinal Gounder from Memorial Sloan Kettering Cancer Center in New York, New York, summarize the treatment landscape for desmoid tumors and review novel options for targeted therapy.
    18 October 2024, 7:39 pm
  • 2 hours 14 minutes
    Striving for Consensus: Optimizing the Current and Future Management of Biliary Tract Cancers
    Dr Lipika Goyal from Stanford Cancer Center in Palo Alto, California, Dr James J Harding from Memorial Sloan Kettering Cancer Center in New York, New York, Dr Milind Javle from The University of Texas MD Anderson Cancer Center in Houston, Texas, and Dr Robin K (Katie) Kelley from UCSF Helen Diller Family Comprehensive Cancer Center in San Francisco, California, summarize the treatment landscape for patients with biliary tract cancers and review recent advancements in the field.
    20 September 2024, 8:32 pm
  • 59 minutes 19 seconds
    Inside the Issue: Optimizing the Diagnosis and Treatment of Neuroendocrine Tumors
    Dr Pamela Kunz from the Yale School of Medicine and Yale Cancer Center in New Haven, Connecticut, and Dr Simron Singh from the Odette Cancer Centre and Sunnybrook Health Sciences Centre in Toronto, Ontario, Canada, discuss optimizing the diagnosis and treatment of neuroendocrine tumors.
    19 September 2024, 3:25 pm
  • 1 hour 58 seconds
    Inside the Issue: Integrating HER2-Targeted Strategies into the Management of Gastrointestinal Cancers
    Dr Tanios Bekaii-Saab from the Mayo Clinic Cancer Center in Phoenix, Arizona, and Dr John Strickler from Duke University in Durham, North Carolina, review clinical data supporting the application of HER2-targeted therapies for patients with gastrointestinal cancers.
    13 September 2024, 9:34 pm
  • 1 hour 15 minutes
    Oncology Today with Dr Neil Love: Optimizing the Management of Dedifferentiated Liposarcoma
    Dr Mrinal Gounder from Memorial Sloan Kettering Cancer Center in New York, New York, discusses recent updates on available and emerging treatment strategies for dedifferentiated liposarcoma and other sarcomas.
    10 September 2024, 5:45 pm
  • 1 hour 2 minutes
    RTP Live from Chicago: Investigator Perspectives on Recent Advances and Challenging Questions in the Management of Colorectal Cancer
    Dr Scott Kopetz from The University of Texas MD Anderson Cancer Center in Houston, and Dr John Strickler from Duke University in Durham, North Carolina, discuss recent updates on available and novel treatment strategies for colorectal cancer.
    16 July 2024, 6:36 pm
  • 59 minutes 46 seconds
    Year in Review: Novel Treatments and Strategies in Gastroesophageal Cancer
    Prof Eric Van Cutsem from University Hospitals Leuven in Leuven, Belgium, discusses recent updates on available and novel treatment strategies for gastroesophageal cancer.
    3 May 2024, 8:10 pm
  • 37 minutes 24 seconds
    Oncology Today with Dr Neil Love: Role of HER2-Directed Therapy in the Treatment of HER2-Expressing Gastrointestinal Cancers — Part 2 of a Special 3-Part Edition
    Dr Kanwal Raghav from The University of Texas MD Anderson Cancer Center in Houston discusses the role of HER2-directed therapy in the treatment of gastrointestinal tumors beyond gastroesophageal cancer.
    16 April 2024, 4:57 pm
  • 58 minutes 42 seconds
    Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Colorectal Cancer
    Professor Thierry André from the Hôpital Saint-Antoine in Paris, France, and Dr Arvind Dasari from MD Anderson Cancer Center in Houston, Texas, discuss recent developments regarding available and novel treatment strategies for colorectal cancer.
    8 April 2024, 4:59 pm
  • 1 hour 1 minute
    Consensus or Controversy? Immune Checkpoint Inhibitors in the Management of Hepatobiliary Cancers — A 2024 Post-ASCO Gastrointestinal Cancers Symposium Review
    Dr Robin K (Katie) Kelley from the UCSF Helen Diller Family Comprehensive Cancer Center in San Francisco, California, and Dr Mark Yarchoan from the Johns Hopkins Sidney Kimmel Cancer Center in Baltimore, Maryland, discuss clinical decision-making with numerous treatment strategies for hepatocellular carcinoma and biliary tract cancers.
    21 March 2024, 3:43 pm
  • More Episodes? Get the App
About Gastrointestinal Cancer Update
Links
Listeners Also Subscribed To
© MoonFM 2024. All rights reserved.